Table 1 Patients’ characteristics.

Age, years (median, [range])

73 [49, 91]

PSA, ng/mL (median [range])

7.84 [0.49, 4504.00]

Median prostate volume (mL, [range])

38.5 [13.0, 210.0]

PI-RADS score, n (%)

3

6 (17.1)

4

16 (45.7)

5

13 (37.1)

Biopsy method, n (%)

MRI/US fusion

31 (77.5)

Systematic

9 (22.5)

Total number of biopsy cores

443

Median number of biopsy cores/patient (n, [range])

12 [4, 15]

Total number of divided biopsy cores, n (%)

361/443 (81.5)

Median number of divided cores/patient (n, [range])

10 [2, 14]

Diagnosed with cancer, n (%)

28 (70.0)

Median core length (mm, [range])

11.0 [1.0, 22.0]

Median cancer core length (mm, [range])

6.0 [0.2, 20.0]

ISUP Grade Group, n (%)

2

7/28 (25.0)

3

3/28 (10.7)

4

9/28 (32.1)

5

9/28 (32.1)